Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00329732 · ClinicalTrials.gov registry record · NA
Research Study of Greater Occipital Nerve Block As A Treatment For Prolonged Migraine Attacks
A NA study, sponsored by Thomas Jefferson University.
- Terminated
- Registry status
- NA
- Development phase
- 2
- Enrollment target
NCT00329732: Clinical Trial NA study, sponsored by Thomas Jefferson University.
NCT00329732 is a NA study that was terminated before completion, run by Thomas Jefferson University. The registered enrollment target is 2 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00329732, a NA study, was terminated before completion, sponsored by Thomas Jefferson University.
- TERMINATED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
Study Summary
Greater Occipital Nerve Blocks (GONB) are a common procedure used for the treatment of headache. The GONB procedure involves a series of injections into the greater occipital nerve (a spinal nerve located at the back of your head). The purpose of this study is to determine whether GONB is effective for the treatment of prolonged migraine attacks. This study is placebo controlled, which means that half of the patients participating will receive injections of active study drug (lidocaine plus bupivicaine) and half of the patients will receive injections of saline (placebo). The study is also blinded which means that neither you nor the study staff will know whether you received active study drug or placebo. The study remains blinded only for the first 30 minutes, at which point additional treatments (including GONB) can be administered at the discretion of your treating physician. 40 patients are expected to participate in this research study. This study is being conducted at Thomas Jefferson University only.
Interventions
- DRUG Saline placebo
- DRUG 0.5% bupivicaine and 2% lidocaine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2006-03 |
| Est. Completion | 2006-04 |
| Phase | NA |
Why NCT00329732 stopped before completion
NCT00329732 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 2 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 2 interventions - of which Saline placebo is the first listed.
NCT00329732 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00329732 about?
NCT00329732 is a clinical study titled "Research Study of Greater Occipital Nerve Block As A Treatment For Prolonged Migraine Attacks". Greater Occipital Nerve Blocks (GONB) are a common procedure used for the treatment of headache. The GONB procedure involves a series of injections into the greater occipital nerve (a spinal nerve located at the back of your head). The purpose of this study is to determine whether GONB is effective ...
What is the current status of trial NCT00329732?
This trial is currently terminated. It is a NA study. The enrollment target is 2 participants. The study started on 2006-03. Estimated completion is 2006-04.
What interventions are being tested in trial NCT00329732?
The interventions under investigation include: Saline placebo (DRUG), 0.5% bupivicaine and 2% lidocaine (DRUG).
Who is sponsoring clinical trial NCT00329732?
This trial is sponsored by Thomas Jefferson University, which has 292 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00329732's enrollment target sits among peer trials
2 1997th of 2000 the lowest of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia